Clinical Trial: DESIFOR-EXPAND (MHIF)

U.S., Feb. 4 -- ClinicalTrials.gov registry received information related to the study (NCT06804980) titled 'DESIFOR-EXPAND (MHIF)' on Jan. 23.

Brief Summary: The DESIFOR pilot study was conducted to determine the feasibility of utilizing an n-of-1 trial to facilitate tolerance of unblinded rosuvastatin in patients with prior statin intolerance

Study Start Date: Feb. 01

Study Type: INTERVENTIONAL

Condition: Statin Therapy Statin Adverse Reaction Statin

Intervention: DRUG: Rosuvastatin (Crestor)

The patient will take 3 28-day packs of placebo and 2 28-day packs of rosuvastatin. The order in which they take the placebo or rosuvastatin will be assigned at random.

DRUG: Placebo

The patient will take 3 28-day packs of placebo and 2 28-d...